Eicosapentaenoic acid (EPA) in reducing secondary cardiovascular events in hypercholesterolemic Japanese patients

Circ J. 2009 Jul;73(7):1197-8. doi: 10.1253/circj.cj-09-0331.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood
  • Eicosapentaenoic Acid / therapeutic use*
  • Fatty Acids, Omega-3 / therapeutic use
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / complications*
  • Incidence
  • Japan / epidemiology

Substances

  • Cholesterol, LDL
  • Fatty Acids, Omega-3
  • Eicosapentaenoic Acid